Rankings
▼
Calendar
BBLG FY 2017 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena
BBLG
Bone Biologics Corporation
$2M
FY 2017 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$0
Gross Profit
-$96
Operating Income
-$3M
Net Income
-$7M
EPS (Diluted)
$-6480.00
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
-$584,027
Balance Sheet
Total Assets
$795,659
Total Liabilities
$9M
Stockholders' Equity
-$8M
Cash & Equivalents
$690,279
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$96
-$700
+86.3%
Operating Income
-$3M
-$20M
+87.1%
Net Income
-$7M
-$26M
+72.8%
← Q4 2016
All Quarters
Q1 2017 →